SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-048017
Filing Date
2010-03-04
Accepted
2010-03-04 17:18:41
Documents
9
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1235257
2 WARRANT TO PURCHASE STOCK AGREEMENT dex419.htm EX-4.19 45504
3 EXCLUSIVE OPTION AGREEMENT dex1027.htm EX-10.27 36606
4 EMPLOYMENT AGREEMENT dex1053.htm EX-10.53 47143
5 CONSENT OF KPMG LLP dex231.htm EX-23.1 2351
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 9209
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 9207
8 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex321.htm EX-32.1 6087
9 GRAPHIC g41469logo.jpg GRAPHIC 11545
  Complete submission text file 0001193125-10-048017.txt   1409028
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22873 | Film No.: 10658127
SIC: 2835 In Vitro & In Vivo Diagnostic Substances